CytoMed Therapeutics (GDTC) Shares Issued (2021 - 2022)
CytoMed Therapeutics' Shares Issued came in at $350,543 for Q4 2022, down 49.9% from $699,378 a year earlier.
Powered by 
Analysis
CytoMed Therapeutics (GDTC) Shares Issued (2021 - 2022) Analysis & Trends
For FY2022, CytoMed Therapeutics' Shares Issued was $353,003, down 50.0% from FY2021.
- Going back by year, Shares Issued was $706,552 in FY2021 (+300.5%) and $176,401 in FY2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | CytoMed Therapeutics | 9.94 Mn | -1.15 Mn | - | - |
API Access
CytoMed Therapeutics Shares Issued API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-issued&ticker=GDTC&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-issued", "ticker": "GDTC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-issued&ticker=GDTC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();